The Human Osteocalcin ELISA quantitates Hu Osteocalcin in human serum, plasma, cell culture supernatants, urine, amniotic fluid, bile, or other body fluids. The assay will exclusively recognize both natural and recombinant Hu Osteocalcin. Principle…
The Human Osteocalcin ELISA quantitates Hu Osteocalcin in human serum, plasma, cell culture supernatants, urine, amniotic fluid, bile, or other body fluids. The assay will exclusively recognize both natural and recombinant Hu Osteocalcin. Principle of the method The Human Osteocalcin solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the binding of the second (detector) antibody to the target on a different epitope from the capture antibody. An antibody conjugated with enzyme binds the formed sandwich. After incubation and washing steps to rid the microplate of unbound substances, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
L-osteocalcin belongs to the d-osteocalcin/Gla protein matrix family and constitutes 1-2 % of the total bone protein. It binds strongly to apatitis and calcium. The residues of gamma-carboxyglutamate are formed by vitamin K-dependent carboxylation. These residues are essential for calcium binding.
Sensitivity
Sensitivity of dosage: 0.2 ng.
Measurement range
Dose range: 1.2-75 ng/ml.
Duration of dosing
Total duration of dosing: 2 h 10 min.
Reproducibility
Coefficient of intra-dose variation 8.3%, inter-dose 8.1%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15571507 |
| Specifications |
| Accession number | P02818 |
| Dose range | 1.2-75 ng/ml |
| Sensitivity of the dosage | 0.2 ng |
| Conjugate | HRP |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 632 |
| Gene symbol(s) | BGP,OC,OCN |
| Coefficient of inter-dose variation | 8.1% |
| Coefficient of intra-dose variation | 8.3% |
| Contents of kits | 10x lysis pad, Adhesive plate covers, Antibodies detection, Antibodies detection, lyophilized, 96 well pre-coated microplate, Sample thinner, Standard curve strips, Standard curve bands, Wash buffer concentrate, Substrate solution |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Protein containing gamma-carboxyglutamic acid |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 25 μl; serum, 25 μl; supernatant, 25 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 2 h 10 min |
Origin and customs
| Manufacturer ref. | BMS2020INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.